Omnicell (OMCL)
(Delayed Data from NSDQ)
$29.31 USD
+0.02 (0.07%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $29.55 +0.24 (0.82%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for Omnicell, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,147 | 1,296 | 1,132 | 892 | 897 |
Cost Of Goods | 650 | 707 | 577 | 479 | 460 |
Gross Profit | 497 | 589 | 555 | 413 | 437 |
Selling & Adminstrative & Depr. & Amort Expenses | 532 | 591 | 465 | 378 | 359 |
Income After Depreciation & Amortization | -35 | -2 | 90 | 36 | 78 |
Non-Operating Income | 15 | 0 | -24 | -6 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 4 |
Pretax Income | -20 | -2 | 66 | 29 | 74 |
Income Taxes | 0 | -8 | -12 | -3 | 13 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -20 | 6 | 78 | 32 | 61 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -20 | 6 | 78 | 32 | 61 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 65 | 101 | 196 | 113 | 145 |
Depreciation & Amortization (Cash Flow) | 100 | 103 | 107 | 78 | 66 |
Income After Depreciation & Amortization | -35 | -2 | 90 | 36 | 78 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 45.21 | 45.89 | 47.94 | 43.74 | 42.94 |
Diluted EPS Before Non-Recurring Items | 0.95 | 1.81 | 2.78 | 1.74 | 2.19 |
Diluted Net EPS (GAAP) | -0.45 | 0.12 | 1.62 | 0.74 | 1.43 |
Fiscal Year end for Omnicell, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 246.15 | 258.85 | 298.66 | 298.97 |
Cost Of Goods | NA | 153.53 | 153.44 | 166.70 | 164.53 |
Gross Profit | NA | 92.62 | 105.40 | 131.96 | 134.44 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 114.47 | 128.77 | 128.25 | 126.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -21.85 | -23.37 | 3.71 | 7.74 |
Non-Operating Income | NA | 4.02 | 8.52 | 0.00 | 4.46 |
Interest Expense | NA | 0.00 | 3.67 | -3.67 | 0.00 |
Pretax Income | NA | -17.83 | -18.52 | 7.38 | 12.21 |
Income Taxes | NA | -2.16 | -4.14 | 1.83 | 8.76 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -15.68 | -14.38 | 5.55 | 3.45 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -15.68 | -14.38 | 5.55 | 3.45 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 45.73 | 45.50 | 45.60 | 45.47 |
Diluted EPS Before Non-Recurring Items | NA | -0.14 | 0.12 | 0.36 | 0.29 |
Diluted Net EPS (GAAP) | NA | -0.34 | -0.32 | 0.12 | 0.08 |